Research Paper (606)

  • [La diagnosi psicopatologica nel lavoro psicologico-psichiatrico]
    [La diagnosi psicopatologica nel lavoro psicologico-psichiatrico]

    Roberto Infrasca

    Get Access
  • Cognitive-Behavioral and Pharmacological Treatments for Insomnia: A Combined Approach
    Cognitive-Behavioral and Pharmacological Treatments for Insomnia: A Combined Approach

    Alessandro Cicolin

    Get Access
  • 4Q Model: How to Apply Guidelines for COPD in Primary Care
    4Q Model: How to Apply Guidelines for COPD in Primary Care

    Carla Bruschelli

    Get Access
  • Statins and Immune-Mediated Necrotizing Myopathy
    Statins and Immune-Mediated Necrotizing Myopathy

    Mauro Turrin

    Get Access
  • Safety of belimumab in association with denosumab in a patient affected by Lupus Erythematosus: a case report
    Safety of belimumab in association with denosumab in a patient affected by Lupus Erythematosus: a case report

    Marco Scarati

    Get Access
  • Gender-related differences in dietary habits
    Gender-related differences in dietary habits

    Roberta Masella

    Get Access
  • Usefulness of the blood chemistry screening associated with DXA imaging in a case of secondary osteoporosis in a young adult
    Usefulness of the blood chemistry screening associated with DXA imaging in a case of secondary osteoporosis in a young adult

    Valerio Massimo Magro

    Get Access
  • A complicated case of atrial fibrillation
    A complicated case of atrial fibrillation

    Erica Delsignore

    Get Access
  • Diaphragmatic flutter in a patient with a pacemaker
    Diaphragmatic flutter in a patient with a pacemaker

    Carlo Bussolino

    Get Access
  • The use of nilotinib in clinical practice: monitoring effectiveness and tolerability
    The use of nilotinib in clinical practice: monitoring effectiveness and tolerability

    Giorgina Specchia

    Get Access
  • Different response to imatinib and nilotinib in relationship with the time of administration
    Different response to imatinib and nilotinib in relationship with the time of administration

    Paolo Danise

    Get Access
  • Resistant hypertension in atherosclerotic renovascular disease
    Resistant hypertension in atherosclerotic renovascular disease

    Angelo Bosio

    Get Access
  • Treatment of lung microcytoma with neuroendocrine differentiation in elderly patient
    Treatment of lung microcytoma with neuroendocrine differentiation in elderly patient

    Alessandra Bearz

    Get Access
  • Efficacy of nilotinib in a patient in late chronic phase CML, intolerant to imatinib and resistant to dasatinib
    Efficacy of nilotinib in a patient in late chronic phase CML, intolerant to imatinib and resistant to dasatinib

    Emilio Usala

    Get Access
  • [Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]
    [Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]

    Fabio Tarsetti

    Get Access
  • Efficacy and safety of nilotinib as third-line therapy in an elderly patient with CML
    Efficacy and safety of nilotinib as third-line therapy in an elderly patient with CML

    Giovanni Caocci

    Get Access
  • Efficacy of nilotinib in a patient relapse after 9 years of imatinib treatment and in stable complete cytogenetic response
    Efficacy of nilotinib in a patient relapse after 9 years of imatinib treatment and in stable complete cytogenetic response

    Marzia Defina

    Get Access
  • A case of serious bleeding
    A case of serious bleeding

    Irene Ricca

    Get Access
  • Efficacy of nilotinib as third-line treatment in a patient with very late Chronic Myeloid Leukemia and a possibile cardiologic contraindication
    Efficacy of nilotinib as third-line treatment in a patient with very late Chronic Myeloid Leukemia and a possibile cardiologic contraindication

    Ester Maria Orlandi

    Get Access
  • Fidaxomicin in the treatment of colitis due to Clostridium difficile: preliminary results
    Fidaxomicin in the treatment of colitis due to Clostridium difficile: preliminary results

    Francesco Cortese

    Get Access
  • Could (Disseminated and Residual) Minimal Disease be a useful prognostic marker in non-Hodgkin paediatric Lymphomas?
    Could (Disseminated and Residual) Minimal Disease be a useful prognostic marker in non-Hodgkin paediatric Lymphomas?

    Lara Mussolin

    Get Access
  • [Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life]
    [Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life]

    Francesco Saverio Mennini

    Get Access
  • Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis
    Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis

    Marco Bellone

    Get Access
  • Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy
    Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy

    Patrizia Berto

    Get Access
  • Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis
    Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis

    Francesco Mennini

    Get Access
  • The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness
    The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness

    Pietro Ferrara

    Get Access
  • [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]
    [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]

    Elena Galli

    Get Access
  • Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy
    Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy

    Massimiliano Povero

    Get Access
  • A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel
    A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel

    Cristian Scatena

    Get Access
  • Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective
    Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective

    Daniela Paola Roggeri

    Get Access

Your Feedback